184 related articles for article (PubMed ID: 24883303)
1. Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.
Levidou G; Sachanas S; Pangalis GA; Kalpadakis C; Yiakoumis X; Moschogiannis M; Sepsa A; Lakiotaki E; Milionis V; Kyrtsonis MC; Vassilakopoulos TP; Tsirkinidis P; Kontopidou F; Kokoris S; Siakantaris M; Angelopoulou M; Papadaki H; Kavantzas N; Panayiotidis P; Patsouris E; Korkolopoulou P
Biomed Res Int; 2014; 2014():251479. PubMed ID: 24883303
[TBL] [Abstract][Full Text] [Related]
2. Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors.
Korkolopoulou P; Levidou G; El-Habr EA; Adamopoulos C; Samaras V; Zisakis A; Kavantzas N; Boviatsis E; Fragkou P; Papavassiliou AG; Patsouris E; Piperi C
Mol Med; 2012 May; 18(1):379-88. PubMed ID: 22231733
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry.
Piperi C; Samaras V; Levidou G; Kavantzas N; Boviatsis E; Petraki K; Grivas A; Barbatis C; Varsos V; Patsouris E; Korkolopoulou P
Cytokine; 2011 Sep; 55(3):387-95. PubMed ID: 21684758
[TBL] [Abstract][Full Text] [Related]
4. The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma.
Stofas A; Levidou G; Piperi C; Adamopoulos C; Dalagiorgou G; Bamias A; Karadimou A; Lainakis GA; Papadoukakis S; Stravodimos K; Dimopoulos MA; Patsouris E; Gakiopoulou H; Korkolopoulou P
BMC Cancer; 2014 Mar; 14():149. PubMed ID: 24593195
[TBL] [Abstract][Full Text] [Related]
5. EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.
Szurián K; Csala I; Marosvári D; Rajnai H; Dezső K; Bödör C; Piurkó V; Matolcsy A; Reiniger L
Exp Mol Pathol; 2018 Oct; 105(2):161-165. PubMed ID: 30031020
[TBL] [Abstract][Full Text] [Related]
6. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
[TBL] [Abstract][Full Text] [Related]
7. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
Isomoto H; Mott JL; Kobayashi S; Werneburg NW; Bronk SF; Haan S; Gores GJ
Gastroenterology; 2007 Jan; 132(1):384-96. PubMed ID: 17241887
[TBL] [Abstract][Full Text] [Related]
8. [Expression and Clinical Significance of Helper T Cells 9 and Its Sytokines Interleukin 9 in Chronic Lymphocytic Leukemia].
Shabaaiti T; Pang NN; Xierenguli A; Nazhakaiti Y; Guo S; Zhang RR; Gong S; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1663-1669. PubMed ID: 38071043
[TBL] [Abstract][Full Text] [Related]
9. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
10. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
11. Lymph node metastasis is mediated by suppressor of cytokine signaling-3 in gastric cancer.
Deng J; Jiao X; Liu H; Wu L; Zhang R; Wang B; Pan Y; Hao X; Liang H
Tumour Biol; 2013 Dec; 34(6):3627-36. PubMed ID: 23824571
[TBL] [Abstract][Full Text] [Related]
12. Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma - proliferation centres are characterized by high miR-92a and miR-155 and low miR-150 expression.
Szurián K; Csala I; Piurkó V; Deák L; Matolcsy A; Reiniger L
Leuk Res; 2017 Jul; 58():39-42. PubMed ID: 28407516
[TBL] [Abstract][Full Text] [Related]
13. Increased autocrine interleukin-6 production is significantly associated with worse clinical outcome in patients with chronic lymphocytic leukemia.
Wang HQ; Jia L; Li YT; Farren T; Agrawal SG; Liu FT
J Cell Physiol; 2019 Aug; 234(8):13994-14006. PubMed ID: 30623437
[TBL] [Abstract][Full Text] [Related]
14. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
[TBL] [Abstract][Full Text] [Related]
15. IL-6, IL-10, c-Jun and STAT3 expression in B-CLL.
Antosz H; Wojciechowska K; Sajewicz J; Choroszyńska D; Marzec-Kotarska B; Osiak M; Pająk N; Tomczak W; Jargiełło-Baszak M; Baszak J
Blood Cells Mol Dis; 2015 Mar; 54(3):258-65. PubMed ID: 25477266
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemia.
Sachanas S; Levidou G; Angelopoulou MK; Moschogiannis M; Yiakoumis X; Kalpadakis C; Vassilakopoulos TP; Kontopidou F; Tsirkinidis P; Dimitrakopoulou A; Kokoris S; Dimitriadou E; Kyrtsonis MC; Panayiotidis P; Papadaki H; Patsouris E; Korkolopoulou P; Pangalis GA
Leuk Lymphoma; 2014 Mar; 55(3):571-82. PubMed ID: 23697878
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
19. Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.
Murphy C; McGurk M; Pettigrew J; Santinelli A; Mazzucchelli R; Johnston PG; Montironi R; Waugh DJ
Clin Cancer Res; 2005 Jun; 11(11):4117-27. PubMed ID: 15930347
[TBL] [Abstract][Full Text] [Related]
20. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Soma LA; Craig FE; Swerdlow SH
Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
